Trinity Biotech votes pass with at least 95% support

The resolutions also re-appointed Dr Andrew Omidvar as a director and authorized the board to set statutory auditor remuneration.

Rhea-AI Filing Summary

Trinity Biotech plc reported that shareholders at its September 30, 2026 annual general meeting approved all proposed resolutions, each with at least 95% of votes cast.

Shareholders re-appointed Grant Thornton as statutory auditor until the conclusion of the next annual general meeting at which accounts are laid before the company, authorized the board to fix the statutory auditor’s remuneration, and re-appointed Dr Andrew Omidvar as a director.

Key Figures

Minimum approval: 95% of votes cast

1 metrics

Minimum approval 95% of votes cast Minimum approval for the proposed resolutions

Key Terms

statutory auditor, requisite majorities, votes cast

3 terms

statutory auditor regulatory

"re-appointed Grant Thornton as statutory auditor"

A statutory auditor is an independent, legally required accountant who examines a company’s financial records and issues an official opinion on whether the financial statements give a true and fair view. Investors rely on this check as a trusted third-party stamp—like a certified inspection—because it reduces the chance that errors, omissions or rule-breaking will mislead people making investment decisions.

requisite majorities regulatory

"approved all of the resolutions proposed by the requisite majorities"

votes cast regulatory

"minimum approval of 95% of votes cast"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did TRIB shareholders approve at the 2026 annual general meeting?

Shareholders approved all proposed resolutions at the September 30, 2026 meeting. They re-appointed Grant Thornton as statutory auditor, authorized the board to fix the auditor’s remuneration, and re-appointed Dr Andrew Omidvar as a director.

How much support did TRIB’s annual meeting resolutions receive?

Each resolution received at least 95% of votes cast.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/05/2026 - 07:22 AM Accepted by SEC EDGAR 10/05/2026 - 07:22 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2026

TRINITY BIOTECH PLC

(Name of Registrant)

IDA Business Park

Bray, Co. Wicklow, Ireland

(Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

This Form 6-K is being incorporated by reference into our Registration Statements on Form S-8 (File Nos. 333-182279, 333-195232 and 333-253070) and Form F-3 (File Nos. 333-267160, 333-286020, 333-295842 and 333-280391).

EXPLANATORY NOTE

Trinity Biotech plc Announces Results of Annual General Meeting

At the annual general meeting (the “Meeting”) of the Company held on September 30, 2026, shareholders approved all of the resolutions proposed by the requisite majorities and with a minimum approval of 95% of votes cast.

The resolutions (the text of which is more fully set out in the notice of meeting dated September 4, 2026) were as follows:

1. To re-appoint Grant Thornton as statutory auditor of the Company to hold office until the conclusion of the next annual general meeting at which accounts are laid before the Company.

2. To authorise the board of directors to fix the statutory auditors’ remuneration.

3. To re-appoint Dr Andrew Omidvar as a director of the Company.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	TRINITY BIOTECH PLC
		Trinity Biotech plc
		(Registrant)
	By:	/s/ Paul Murphy
		Paul Murphy
		Interim Chief Financial Officer

Date: October 5, 2026